Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $43.49 million. The enterprise value is $24.11 million.

Market Cap	43.49M
Enterprise Value	24.11M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

GRCE has 13.83 million shares outstanding. The number of shares has increased by 28.20% in one year.

Current Share Class	13.83M
Shares Outstanding	13.83M
Shares Change (YoY)	+28.20%
Shares Change (QoQ)	+15.14%
Owned by Insiders (%)	21.58%
Owned by Institutions (%)	10.96%
Float	7.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.69
P/TBV Ratio	3.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.87

Current Ratio	8.87
Quick Ratio	8.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -16.78% and return on invested capital (ROIC) is -15.06%.

Return on Equity (ROE)	-16.78%
Return on Assets (ROA)	-13.26%
Return on Invested Capital (ROIC)	-15.06%
Return on Capital Employed (ROCE)	-21.94%
Revenue Per Employee	n/a
Profits Per Employee	-$1.72M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.48M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.00
52-Week Price Change	n/a
50-Day Moving Average	3.11
200-Day Moving Average	2.96
Relative Strength Index (RSI)	58.42
Average Volume (20 Days)	76,316

Short Selling Information

The latest short interest is 23,235, so 0.17% of the outstanding shares have been sold short.

Short Interest	23,235
Short Previous Month	352,260
Short % of Shares Out	0.17%
Short % of Float	0.31%
Short Ratio (days to cover)	0.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.80M
Pretax Income	-12.79M
Net Income	-10.31M
EBITDA	-14.80M
EBIT	-14.80M
Earnings Per Share (EPS)	-$0.77

Full Income Statement

Balance Sheet

The company has $20.01 million in cash and n/a in debt, giving a net cash position of $20.01 million or $1.45 per share.

Cash & Cash Equivalents	20.01M
Total Debt	n/a
Net Cash	20.01M
Net Cash Per Share	$1.45
Equity (Book Value)	63.55M
Book Value Per Share	4.60
Working Capital	18.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-13.11M
Capital Expenditures	n/a
Free Cash Flow	-13.11M
FCF Per Share	-$0.95

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.20%
Shareholder Yield	-28.20%
Earnings Yield	-23.38%
FCF Yield	-29.72%

Analyst Forecast

The average price target for GRCE is $12.00, which is 281.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	281.56%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 1:6.

Last Split Date	Jul 10, 2023
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1